课题基金 / 基金详情

Center for Herbal Research on Colorectal Cancer

Center for Herbal Research on Colorectal Cancer
结直肠癌草药研究中心
批准号:
8299547
负责人:
CHUN-SU YUAN
金额:
$115.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-30 至 2015-01-31

项目摘要

项目成果

CHUN-SU YUAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Colorectal cancer is the second most prevalent cancer and the second leading cause of cancer related death in the United States. Botanicals could potentially have anti-cancer compounds that may be used alone or as adjuncts to existing chemotherapy to improve efficacy and reduce the drug-induced toxicity. Identifying herbal sources to develop ideal chemoprevention remains an essential step in advancing the treatment of this cancer and will be addressed in the proposed project. The current proposal postulates based on convincing preliminary results and literature reports that two specific herbs from the ginseng family, steamed or unsteamed roots of American ginseng and notoginseng, may have significant anti-cancer activities. The aim of this project is to thoroughly characterize the anti-proliferative actions of test herbs and the underlying mechanisms of action in their direct and adjuvant anti-cancer effects. We hypothesize that American ginseng and notoginseng, particularly after steaming preparation, are effective tumoricidal and chemo-adjuvant compounds against human colorectal cancer. In the proposed project, we will test the tumoricidal effects of these two ginseng herbs on distinct human colorectal cancer cell lines and a mouse xenograft model, and determine the involved mechanisms. We will further test whether the extracts potentiate the tumoricidal effects of colon cancer chemotherapeutic agents, 5-fluorouracil and irinotecan, using the cell lines and mouse model. If synergistic interactions between test herbs and chemotherapeutic drugs exist, then it will enable lowering of the drug dose thus reducing the dose-related toxicity. In addition, whether the newly identified active constituents from steamed herbs increase chemotherapeutic agents' activity will be determined. Finally, pharmacokinetic interaction between the chemotherapeutic drugs and the test herbs, if any, will be characterized. A novelty of this project is the use of "knockout" herbal extracts which will allow a more conclusive association of the effect of the herbal extract to the responsible active constituent(s). Data from the proposed study have a potential to improve treatment regimens and the quality of life for patients suffering from colorectal cancer.
期刊论文(83)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.gendis.2014.08.004
发表时间: 2014-09
期刊: GENES & DISEASES
影响因子: 6.8
作者: [Zhang, Hongmei, Yan, Zhengjian, Li, Melissa, Peabody, Michael, He, Tong-Chuan]
通讯作者: He, Tong-Chuan
DOI: 10.1016/j.canlet.2010.11.015
发表时间: 2011-02-28
期刊: CANCER LETTERS
影响因子: 9.7
作者: [Li, Binghui, Zhao, Jiong, Wang, Chong-Zhi, Searle, Jennifer, He, Tong-Chuan, Yuan, Chun-Su, Du, Wei]
通讯作者: Du, Wei
DOI: 10.1002/hlca.201300439
发表时间: 2015-02
期刊: Helvetica chimica acta
影响因子: 1.8
作者: [Huang WH, Zhang QW, Wang CZ, Yuan CS, Li SP]
通讯作者: Li SP
DOI: --
发表时间: 2016
期刊:
影响因子: --
作者: [Shun Lu;Jing Wang;Jixing Ye;Y. Zou;Yunxiao Zhu;Q. Wei;Xin Wang;Shengli Tang;Hao Liu]
通讯作者: Shun Lu;Jing Wang;Jixing Ye;Y. Zou;Yunxiao Zhu;Q. Wei;Xin Wang;Shengli Tang;Hao Liu
64
    Center for Herbal Research on Colorectal Cancer
    • 批准号:
      7910395
    • 项目类别:
    • 资助金额:
      $118.8万
    • 财政年份:
      2008
    • 负责人:
      CHUN-SU YUAN
    • 依托单位:
    Center for Herbal Research on Colorectal Cancer
    • 批准号:
      7691352
    • 项目类别:
    • 资助金额:
      $120.0万
    • 财政年份:
      2008
    • 负责人:
      CHUN-SU YUAN
    • 依托单位:
    Center for Herbal Research on Colorectal Cancer
    • 批准号:
      8121645
    • 项目类别:
    • 资助金额:
      $117.61万
    • 财政年份:
      2008
    • 负责人:
      CHUN-SU YUAN
    • 依托单位:
    SAFETY OF GANODERMA LUCIDUM EXTRACT
    • 批准号:
      7604792
    • 项目类别:
    • 资助金额:
      $2.7万
    • 财政年份:
      2007
    • 负责人:
      CHUN-SU YUAN
    • 依托单位:
    海外基金